Alternatives to Paratus Sciences

Leveraging the adaptive immune system to diagnose and treat disease.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Developing novel therapeutics by understanding the complex interplay of biological systems.

Adimab is a biotechnology company that discovers and develops therapeutic antibodies using its proprietary yeast-based platform.

Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Omega Therapeutics is developing a new class of programmable medicines called Epigenomic Controllers.

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.

A global oncology company developing and commercializing innovative cancer treatments.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

AI-guided drug discovery platform for tissue-targeted medicines.

Biopharmaceutical company developing novel therapeutics for cancer and other diseases using chemoproteomics and covalent chemistry.

Developing engineered biologics to harness the immune system for disease treatment.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Mapping cell-cell communication at scale in human tissue.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

Developing novel protein engineering tools for advanced biomanufacturing and therapeutics.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

AI-powered platform for personalized cell therapy development and manufacturing.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Advance every cancer decision.

PFx Biotech is developing a novel platform for the discovery and development of protein-based therapeutics.

Gene therapy company developing transformative treatments for severe genetic diseases.

Gene therapy company developing treatments for rare inherited diseases.

Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.

A biotechnology company focused on extending healthy human lifespan by targeting the biological causes of aging.

Biopharmaceutical company developing antibody therapeutics for cancer and autoimmune diseases.

Developing novel therapeutics for challenging diseases using advanced biological insights.

Develops and manufactures biologics for therapeutic applications.

Global marketplace connecting researchers with human biospecimens for life science research.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

Biotech company focused on designing and developing novel biological solutions.

A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Biosynthesis of cannabinoids and psychedelics using advanced biotechnology.

Ukko is developing novel food allergy and disorder treatments using advanced immunology and plant science.

AI-powered platform for designing novel molecular structures for new medicines.

Biotechnology company

AI-powered platform for antibody discovery and development to create new medicines.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

Clinical-stage biopharma developing precisely designed cancer therapeutics using a proprietary cell-free protein synthesis platform.

A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Biostax provides a cloud-based platform for life sciences research, enabling data integration and analysis.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

SNIPR Biome is a clinical-stage company developing CRISPR-based therapeutics to precisely target and eliminate specific bacteria in the human microbiome.

AI-powered platform accelerating biological research and drug discovery.

Biotechnology company specializing in antibody discovery and development with integrated 'Idea to IND' solutions.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Israeli-UK biotech company developing novel RNA therapeutics for rare genetic diseases.